KINETICS OF THE ACTION OF AMPICILLIN ON ESCHERICHIA COLI. 1963

S J SELIGMAN, and W L HEWITT

Seligman, Stephen J. (University of California, Los Angeles) and William L. Hewitt. Kinetics of the action of ampicillin on Escherichia coli. J. Bacteriol. 85:1160-1164. 1963.-The curve of the number of viable Escherichia coli after exposure to ampicillin can be divided into three phases: a lag phase, a rapid bactericidal phase, and a slow bactericidal phase. Some of the variables affecting the magnitude of the first two of these phases were investigated. Progressive lowering of drug concentration resulted in prolongation of the lag phase and decrease in slope and extent of the rapid bactericidal phase. The production of elongated gram-negative forms and the emergence of a mutant with increased penicillinase activity complicated interpretation of the lower dose curves. With sufficient drug concentration, the length of the lag phase and the slope of the rapid bactericidal curve were independent of the size of inoculum up to 10(8) organisms. Varying pH revealed that maximal activity, as measured by the shortest lag phase and steepest slope of the rapid bactericidal phase, was present at slightly acid pH levels. Increasing pH resulted principally in prolongation of lag phase. With greater acidity, decrease in slope of the rapid bactericidal phase was more prominent. Cultures studied under conditions of lessened metabolic activity exhibited prolonged lag phase and decreased slope and extent of rapid bactericidal phase.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

S J SELIGMAN, and W L HEWITT
March 1978, The Journal of antibiotics,
S J SELIGMAN, and W L HEWITT
June 1962, The Journal of pharmacy and pharmacology,
S J SELIGMAN, and W L HEWITT
September 1973, Pathologie-biologie,
S J SELIGMAN, and W L HEWITT
September 1982, Antimicrobial agents and chemotherapy,
S J SELIGMAN, and W L HEWITT
January 1992, Chemotherapy,
S J SELIGMAN, and W L HEWITT
November 1977, The Journal of antimicrobial chemotherapy,
S J SELIGMAN, and W L HEWITT
August 1976, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!